Postoperative αAdrenergic Stimulation Attenuates Protein Catabolism

Anesthesia and Analgesia

Volumn 82, Issue 2, 1996, Pages 258-263

  Mertes, Norbert ^a   Goeters, Christiane ^a   Kuhmann, Martin ^a   Zander, Josef F ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; BUPIVACAINE; CLONIDINE; CLORAZEPATE DIPOTASSIUM; FENTANYL; GROWTH HORMONE; ISOFLURANE; PANCURONIUM; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THIOPENTAL;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDURAL ANESTHESIA; ESOPHAGUS CANCER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NITROGEN METABOLISM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN METABOLISM; WITHDRAWAL SYNDROME;

ADRENERGIC ALPHA-AGONISTS; ALCOHOLISM; BLOOD PROTEINS; CLONIDINE; ESOPHAGEAL NEOPLASMS; GLUCAGON; GLUCOSE; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; NITROGEN; PARENTERAL NUTRITION, TOTAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROTEINS; STRESS; SURGICAL PROCEDURES, OPERATIVE; XYLITOL;

EID: 0030019630     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199602000-00008     Document Type: Article

References (29)

1. Wilmore DW. Hormonal responses and their effect on metabolism. Surg Clin North Am 1976;6:999-1018.
2. Elwyn HD. Nutritional requirements of the adult surgical patient. Crit Care Med 1980;8:9-20.
3. Stehle P, Mertes N, Zander JF, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet 1989;4:231-3.
4. Ponting GA, Halliday D, Teale JD, Sim AJW. Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone. Lancet 1988;27:438-40.
5. Wernermann J, Decken van der A, Vinnars E. Protein synthesis in skeletal muscle in relation to nitrogen balance after abdominal surgery: the effect of TPN. JPEN J Parenter Enteral Nutr 1986;6:578-82.
6. Georgieff M, Pscheidl E, Götz H, et al. Untersuchungen zum Mechanismus der Reduktion der Proteinkatabolie nach Trauma und bei Sepsis durch Xylit. Anaesthesist 1991;40:85-91.
7. Mason JMcK, Wilmore DW. Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding. Surgery 1986;100:188-97.
8. Ponting GA, Ward HC, Halliday D, Sim AJW. Protein and energy metabolism with biosynthetic human growth hormone in patients on full intravenous nutritional support. JPEN J Parenter Enterai Nutr 1990;14:437-41.
9. Mjaaland M, Unneberg K, Larsson J, et al. Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition. Ann Surg 1993;217,4:413-22.
10. Ward MWN, Owens CWI, Rennie MJ. Nitrogen estimation in biological samples by use of chemiluminescence. Clin Chem 1993;26:4336-9.
11. Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone-alphadolone. BMJ 1974;22: 656-9.
12. Verner Lj, Hartmann M, Seitz W. Clonidinsupplementierte Analgosedierung zur postoperativen Delirprophylaxe. AINS 1990;25:274-80.
13. Quintin I, Bonnet F, Macquin I, et al. Aortic surgery: effect of clonidine in intraoperative catecholaminergic and circulatory stability. Acta Anaesthesiol Scand 1990;34:132-7.
14. Quintin I, Roudot F, Roux C, et al. Effect of clonidine on the circulation and vasoactive hormones after aortic surgery. Br J Anaesth 1991;66:108-15.
15. Delaunay L, Bonnet F, Duvaldestin P. Clonidine decreases postoperative oxygen consumption in patients recovering from general anaesthesia. Br J Anaesth 1991;67:397-401.
16. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.
17. Bernard J-M, Hommeril JL, Passuti N, Pinaud M. Postoperative analgesia by intravenous clonidine. Anesthesiology 1991;75: 577-82.
18. Devesa J, Arce V, Lois N, et al. Alpha-2-adrenergic agonism enhances growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men. J Clin Endocrinol Metab 1990;71:1581-8.
19. Quintin I, Viale JP, Annat G, et al. Oxygen uptake after major abdominal surgery: effect of clonidine. Anesthesiology 1991;74: 236-41.
20. Aho M, Lehtinen A-M, Laatikainen T, Korttila K. Effects of intramuscular clonidine on hemodynamic and plasma β-endorphin response to gynecologic laparoscopy. Anesthesiology 1990; 72:797-802.
21. Schuit FC, Pipeleers DG. Differences in adrenergic recognition by pancreatic A and B cells. Science 1986;232:875-7.
22. Hirose H, Maruyama H, Itoh K, et al. Alpha-2-adrenergic agonism stimulates islet glucagon release fromL perfused rat pancreas: possible involvement of alpha-2A adrenergic receptor subtype. Acta Endocrinol (Copenh) 1992;127:279-83.
23. Oda S, Fujimura H, Sasaki Y, Ohneda A. Alpha-2-adrenergic modulation of glucagon and insulin secretions in sheep. Tohoku J Exp Med 1991;163:101-10.
24. Giustina A, Buffoli MG, Bussi A, et al. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy. Horm Metab Res 1992;24:240-3.
25. Tancer ME, Stein MB, Uhde TW. Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls. Psychoneuroendocrinology 1990;15:253-9.
26. Cavallo L, Acquafredda A, Liuzzi S, et al. Growth hormone release during insulin tolerance, clonidine, arginine and growth hormone releasing hormone tests in short normal children and adolescents. J Endocrinol Invest 1992;15:131-5.
27. Blum WF. Insulin-like growth factors and their binding proteins. In: Ranke MB, ed. Functional endocrinologic diagnostics in children and adolescents. Mannheim: J and J Verlag, 1992: 102-17.
28. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989;10:68-91.
29. Ross R, Miel J, Freeman E, et al. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I. Clin Endocrinol (Oxf) 1991;5:47-54.